Outcomes in retinoblastoma, 1974-2005: The Children's Hospital, Westmead

Clinical and Experimental Ophthalmology

Volumn 35, Issue 1, 2007, Pages 5-12

  Berman, Edwina L ^a   Donaldson, Craig E ^a   Giblin, Michael ^a   Martin, Frank J ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Management; Outcome; Preservation; Retinoblastoma; Visual acuity

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

ARTICLE; AUSTRALIA; CANCER MORTALITY; CANCER RECURRENCE; CATARACT; CHILD; CHILDHOOD CANCER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG FATALITY; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; FACE DEFORMITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OPTIC NERVE ATROPHY; ORBIT INFECTION; ORBIT INJURY; OUTCOMES RESEARCH; PEDIATRIC HOSPITAL; RETINA DETACHMENT; RETINOBLASTOMA; RETINOPATHY; SCAR FORMATION; SECOND CANCER; SEPSIS; VISUAL ACUITY; VITREOUS HEMORRHAGE;

BRACHYTHERAPY; CRYOTHERAPY; DISEASE-FREE SURVIVAL; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PEDIATRIC; HUMANS; HYPERTHERMIA, INDUCED; INFANT; LASER COAGULATION; MALE; NEOPLASM RECURRENCE, LOCAL; NEW SOUTH WALES; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33846701124     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01386.x     Document Type: Article

References (23)

1. Dondey JC, Staffieri S, McKenzie J, Davie G, Elder J. Retinoblastoma in Victoria, 1976-2000: Changing management trends and outcomes. Clin Exp Ophthalmol 2004; 32: 354-9.
2. Moll AC, Kuik DJ, Bouter LM et al. Incidence and survival of retinoblastoma in the Netherlands: A register based study 1862-1995. Br J Ophthalmol 1997; 81: 559-62.
3. Sanders B, Draper G, Kingston J. Retinoblastoma in Great Britain 1969-1980: Incidence, treatment and survival. Br J Ophthalmol 1998; 72: 576-83.
4. Suckling R, Fitzgerald P, Stewart J, Wells E. The incidence and epidemiology of retinoblastoma in New Zealand: A 30 year survey. Br J Cancer 1982; 46: 729-36.
5. Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 1999; 36: 8-18.
6. Abramson DH, Schefler AC. Update on retinoblastoma. Retina 2004; 24: 828-48.
7. Abramson DH, Frank C. Second nonocular tumors in survivors of bilateral retinoblastoma: A possible age effect on radiation-related risk. Ophthalmology 1998; 105: 573-80.
8. Nahum MP, Gdal-On M, Kuten A, Herzl G, Horovitz Y, Arush MWB. Long-term follow-up of children with retinoblastoma. Pediatr Hematol Oncol 2001; 18: 173-9.
9. Ellsworth RM. The practical management of retinoblastoma. Trans Am Ophthalmol Soc 1969; 67: 463-534.
10. Epstein JA, Shields CL, Shields JA. Trends in the management of retinoblastoma: Evaluation of 1196 consecutive eyes during 1974 to 2001. J Pediatr Ophthalmol Strabismus 2003; 40: 196-203.
11. Schlienger P, Campana F, Vilcoq J. Nonocular second primary tumors after retinoblastoma: Retrospective study of 111 patients treated by electron beam radiotherapy with or without TEM. J Clin Oncol 2004; 27: 411-19.
12. Winick NJ, McKenna RW, Shuster JJ et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 1993; 11: 209-17.
13. Shields JA, Shields CL, Meadows AT. Chemoreduction in the management of retinoblastoma. Am J Ophthalmol 2005; 140: 505-6.
14. Wilson MW, Haik BG, Liu T, Merchant TE, Rodriguez-Galindo C. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Am J Ophthalmol 2005; 140: 397-406.
15. Gallie BL, Budning A, Boer GD et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 1996; 114: 1321-8.
16. Murphree AL, Villablanca JG, Deegan WF et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996; 14: 1348-51.
17. Lee V, Hungerford J, Bunce C, Ahmed F, Kingston JP, Lowman P. Globe conserving treatment of the only eye in bilateral retinoblastoma. Br J Ophthalmol 2003; 87: 1374-80.
18. Desjardins L, Chefchaouni MC, Lumbroso L et al. Functional results after treatment of retinoblastoma. J AAPOS 2002; 6: 108-11.
19. Shields CL, Gorry T, Shields JA. Outcome of eyes with unilateral sporadic retinoblastoma based on initial external findings by the family and pediatrician. J Pediatr Ophthalmol Strabismus 2004; 41: 143-9.
20. Hall LS, Ceisler E, Abramson DH. Visual outcomes in children with bilateral retinoblastoma. J AAPOS 1999; 3: 138-42.
21. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma: Analysis of tumor control and risks for recurrence in 457 tumors. Trans Am Ophthalmol Soc 2004; 102: 35-45.
22. Demirci H, Shields CL, Meadows AT, Shields JA. Long-term visual outcome following chemoreduction for retinoblastoma. Arch Ophthalmol 2005; 123: 1525-30.
23. Murphree AL. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol Clin North Am 2005; 18: 41-53.